|
Volumn 7, Issue 3, 2015, Pages 439-447
|
Antiangiogenic ruthenium(ii) benzimidazole complexes, structure-based activation of distinct signaling pathways
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHEMICAL ACTIVATION;
CHLORINE COMPOUNDS;
DISEASES;
METAL COMPLEXES;
PATHOLOGY;
PHOSPHORYLATION;
PYRIDINE;
RUTHENIUM;
ANGIOGENIC FACTOR;
ANTI-ANGIOGENIC ACTIVITY;
ANTI-ANGIOGENIC THERAPY;
ANTIANGIOGENIC AGENT;
CHICK CHORIOALLANTOIC MEMBRANE;
PERTURBATION EFFECT;
RUTHENIUM COMPLEXES;
SIGNALING PATHWAYS;
RUTHENIUM COMPOUNDS;
ANGIOGENESIS INHIBITOR;
BENZIMIDAZOLE DERIVATIVE;
CYCLIN D1;
CYCLIN DEPENDENT KINASE 2;
CYCLIN DEPENDENT KINASE 4;
CYCLIN DEPENDENT KINASE INHIBITOR 1;
CYCLIN DEPENDENT KINASE INHIBITOR 1B;
CYCLIN DEPENDENT KINASE INHIBITOR 2B;
PROTEIN P53;
RUTHENIUM DERIVATIVE;
VASCULOTROPIN;
VASCULOTROPIN RECEPTOR 2;
BENZIMIDAZOLE;
COORDINATION COMPOUND;
RUTHENIUM;
VASCULOTROPIN A;
ANTIANGIOGENIC ACTIVITY;
ANTIANGIOGENIC THERAPY;
ANTIOXIDANT ACTIVITY;
ANTIPROLIFERATIVE ACTIVITY;
APOPTOSIS;
ARTICLE;
CELL CYCLE G0 PHASE;
CELL CYCLE G1 PHASE;
CELL CYCLE PROGRESSION;
CELL DENSITY;
CELL MIGRATION;
CELL POPULATION;
CHICK;
CHORIOALLANTOIS;
DNA DAMAGE;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ELECTROSPRAY MASS SPECTROMETRY;
ENDOTHELIUM CELL;
G1 PHASE CELL CYCLE CHECKPOINT;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
IN VIVO STUDY;
LIPOPHILICITY;
MTT ASSAY;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN PHOSPHORYLATION;
PROTON NUCLEAR MAGNETIC RESONANCE;
REGULATORY MECHANISM;
SIGNAL TRANSDUCTION;
UPREGULATION;
ANGIOGENESIS;
ANIMAL;
BIOLOGICAL MODEL;
C57BL MOUSE;
CELL CYCLE CHECKPOINT;
CELL MOTION;
CHEMISTRY;
CHICKEN;
CYTOLOGY;
DRUG EFFECTS;
MALE;
METABOLISM;
SYNTHESIS;
UMBILICAL VEIN ENDOTHELIAL CELL;
ANGIOGENESIS INHIBITORS;
ANIMALS;
BENZIMIDAZOLES;
CELL CYCLE CHECKPOINTS;
CELL MOVEMENT;
CHICKENS;
COORDINATION COMPLEXES;
DNA DAMAGE;
HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS;
MALE;
MICE, INBRED C57BL;
MODELS, BIOLOGICAL;
NEOVASCULARIZATION, PHYSIOLOGIC;
RUTHENIUM;
SIGNAL TRANSDUCTION;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;
|
EID: 84924980907
PISSN: 17565901
EISSN: 1756591X
Source Type: Journal
DOI: 10.1039/c4mt00312h Document Type: Article |
Times cited : (54)
|
References (44)
|